-
Mashup Score: 0Dr. Shore encourages clinicians to implement hereditary cancer risk assessments in their practices - 2 year(s) ago
“The take-home message is that it’s not a question of if you’re going to start doing a hereditary cancer risk assessment, it’s when,” says Neal D. Shore, MD, FACS.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Dr. Shore encourages clinicians to implement hereditary cancer risk assessments in their practices - 2 year(s) ago
“The take-home message is that it’s not a question of if you’re going to start doing a hereditary cancer risk assessment, it’s when,” says Neal D. Shore, MD, FACS.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Dr. Shore encourages clinicians to implement hereditary cancer risk assessments in their practices - 2 year(s) ago
“The take-home message is that it’s not a question of if you’re going to start doing a hereditary cancer risk assessment, it’s when,” says Neal D. Shore, MD, FACS.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Study shows feasibility of incorporating hereditary cancer risk assessments into community urology practices - 2 year(s) ago
“The traction on this, I think, is really rather remarkable,” says Neal D. Shore, MD, FACS.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0The value of hereditary cancer risk assessment in the community urology practice setting - 2 year(s) ago
At the 2022 ASCO Genitourinary Cancers Symposium, Neal D. Shore, MD, FACS, presented findings of the prospective study, “Hereditary cancer risk assessment in the community urology practice setting.”
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0The value of hereditary cancer risk assessment in the community urology practice setting - 2 year(s) ago
At the 2022 ASCO Genitourinary Cancers Symposium, Neal D. Shore, MD, FACS, presented findings of the prospective study, “Hereditary cancer risk assessment in the community urology practice setting.”
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0The value of hereditary cancer risk assessment in the community urology practice setting - 2 year(s) ago
At the 2022 ASCO Genitourinary Cancers Symposium, Neal D. Shore, MD, FACS, presented findings of the prospective study, “Hereditary cancer risk assessment in the community urology practice setting.”
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0The value of hereditary cancer risk assessment in the community urology practice setting - 2 year(s) ago
At the 2022 ASCO Genitourinary Cancers Symposium, Neal D. Shore, MD, FACS, presented findings of the prospective study, “Hereditary cancer risk assessment in the community urology practice setting.”
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
Dr. Shore on implementing hereditary cancer risk assessments into practice https://t.co/fFFC8SOVq1 #HCRA #GenomicTesting #Urology #Urologist #ProstateCancer